C-myc, not HER-2/neu, correlates with early recurrence of node-negative breast cancers.

被引：0
|
作者：
Schlotter, CM [1 ]
Vogt, U [1 ]
Bosse, U [1 ]
Wassmann, K [1 ]
机构：
[1] Dept Obstet & Gynecol, Ibbenbueren, Germany
来源：
BREAST CANCER RESEARCH AND TREATMENT | 2001年 / 69卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
322
引用
收藏
页码：262 / 262
页数：1
相关论文
共 50 条
  • [1] C-myc, not HER-2/neu, can predict recurrence and mortality of patients with node-negative breast cancer
    Claus M Schlotter
    Ulf Vogt
    Ulrich Bosse
    Berthold Mersch
    Katja Waβmann
    Breast Cancer Research, 5
  • [2] C-myc, not HER-2/neu, can predict recurrence and mortality of patients with node-negative breast cancer
    Schlotter, CM
    Vogt, U
    Bosse, U
    Mersch, B
    Wassmann, K
    BREAST CANCER RESEARCH, 2003, 5 (02) : R30 - R36
  • [3] Genetic profiles of risk of recurrence in node-negative breast cancers.
    Immaneni, A
    Li, Z
    Tsimelzon, A
    Hilsenbeck, SG
    Clark, GC
    Osborne, CK
    Allred, DC
    O'Connell, P
    BREAST CANCER RESEARCH AND TREATMENT, 2001, 69 (03) : 312 - 312
  • [4] HER-2/neu, c-Myc and cyclin-A in human breast cancer
    Tommasi, S
    Giannella, C
    Mangia, A
    Primavera, AT
    Paradiso, A
    Schittulli, F
    INTERNATIONAL JOURNAL OF ONCOLOGY, 1996, 9 (01) : 111 - 115
  • [5] Comparison of serum and tissue HER-2/neu expression in breast and prostate cancers.
    Neaman, IE
    Contois, JH
    Smith, C
    Schwartz, D
    Schwartz, MK
    Yeung, KK
    Allard, WJ
    CLINICAL CHEMISTRY, 2000, 46 (06) : A162 - A162
  • [6] HER-2 in node-negative breast carcinoma: prognostic significance
    Rampaul, RS
    Pinder, SE
    Bell, JA
    Wencyk, P
    Macmillan, DM
    Blamey, RW
    Robertson, JFR
    Ellis, IO
    BRITISH JOURNAL OF SURGERY, 2001, 88 : 6 - 7
  • [7] Comparison of FISH & IHC techniques in the detection of HER-2/neu amplification in breast cancers.
    Unger, M
    Nathanson, KL
    Antin-Ozerkis, D
    Martin, AM
    Shih, HA
    Calzone, KA
    Ward, T
    Mazoyer, S
    Rebbeck, T
    Weber, BL
    AMERICAN JOURNAL OF HUMAN GENETICS, 1999, 65 (04) : A328 - A328
  • [8] Use of adjuvant trastuzumab with chemotherapy in women with small, node-negative, HER2-positive breast cancers.
    McArthur, H. L.
    Mahoney, K.
    Morris, P. G.
    Patil, S.
    Jacks, L. M.
    Howard, J.
    Norton, L.
    Hudis, C.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [9] High expression of lymphocyte-associated genes in node-negative HER2+ breast cancers correlates with lower recurrence rates
    Alexe, Gabricla
    Dalgin, Gul S.
    Scanfeld, Daniel
    Tamayo, Pablo
    Mesirov, Jill P.
    DeLisi, Charles
    Harris, Lyndsay
    Barnard, Nicola
    Martel, Maritza
    Levine, Arnold J.
    Ganesan, Shridar
    Bhanot, Gyan
    CANCER RESEARCH, 2007, 67 (22) : 10669 - 10676
  • [10] C-MYC GENE AMPLIFICATION IN SELECTED NODE-NEGATIVE BREAST-CANCER PATIENTS CORRELATES WITH HIGH-RATE OF EARLY RELAPSE
    ROUXDOSSETO, M
    ROMAIN, S
    DUSSAULT, N
    DESIDERI, C
    PIANA, L
    BONNIER, P
    TUBIANA, N
    MARTIN, PM
    EUROPEAN JOURNAL OF CANCER, 1992, 28A (10) : 1600 - 1604
12345